• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 CD47 的单链可变片段抗体磁性纳米颗粒的构建及其对膀胱癌的治疗作用。

Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer.

机构信息

National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran.

Nanotechnology Research Center & Department of Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 14155-6451, Iran.

出版信息

Nanomedicine (Lond). 2017 Mar;12(6):597-613. doi: 10.2217/nnm-2016-0302. Epub 2017 Feb 10.

DOI:10.2217/nnm-2016-0302
PMID:28186432
Abstract

AIM

To develop a novel anti-CD47 single-chain variable fragment (scFv) functionalized magnetic nanoparticles (MNPs) for targeting bladder cell lines and its applicability in thermotherapy.

MATERIAL & METHODS: An immunized murine antibody phage display library was constructed and screened to isolate anti-CD47 binders. A scFv was selected and conjugated to MNPs which was then utilized to discriminate CD47 bladder cells along with assessing its efficacy in thermotherapy.

RESULTS

An scFv with high affinity to bladder cells was efficiently conjugated to MNPs. Following a hyperthermia treatment, the function of scFv-MNP conjugates led to a considerable reduction in cell viability.

CONCLUSION

The anti-CD47 scFv-MNP conjugate was an effective cancer cell thermotherapy tool that might pave the way for development of bionano-based targeting techniques in both early detection and treatment of cancer.

摘要

目的

开发一种新型抗 CD47 单链可变片段(scFv)功能化磁性纳米颗粒(MNPs),用于靶向膀胱细胞系及其在热疗中的应用。

材料与方法

构建并筛选免疫小鼠抗体噬菌体展示文库,以分离抗 CD47 结合物。选择 scFv 并将其连接到 MNPs 上,然后利用它来区分 CD47 膀胱细胞,并评估其在热疗中的疗效。

结果

高效地将对膀胱细胞具有高亲和力的 scFv 连接到 MNPs 上。在热疗处理后,scFv-MNP 缀合物的功能导致细胞活力显著降低。

结论

抗 CD47 scFv-MNP 缀合物是一种有效的癌症细胞热疗工具,可能为基于生物纳米的癌症早期检测和治疗靶向技术的发展铺平道路。

相似文献

1
Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer.靶向 CD47 的单链可变片段抗体磁性纳米颗粒的构建及其对膀胱癌的治疗作用。
Nanomedicine (Lond). 2017 Mar;12(6):597-613. doi: 10.2217/nnm-2016-0302. Epub 2017 Feb 10.
2
A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway.一种针对人 CD47 的单链抗体片段的新二硫键连接二聚体通过缺氧诱导因子-1α 通路诱导淋巴恶性细胞凋亡。
Cancer Sci. 2011 Jun;102(6):1208-15. doi: 10.1111/j.1349-7006.2011.01925.x. Epub 2011 May 3.
3
A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells.一种针对CD47的双价单链Fv片段可诱导白血病细胞凋亡。
Biochem Biophys Res Commun. 2004 Mar 19;315(4):912-8. doi: 10.1016/j.bbrc.2004.01.128.
4
Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery.单链抗 c-Met 抗体偶联纳米颗粒用于体内肿瘤靶向成像和药物递送。
Biomaterials. 2011 Apr;32(12):3265-74. doi: 10.1016/j.biomaterials.2010.12.061.
5
Soluble Expression and Characterization of a New scFv Directed to Human CD123.一种针对人CD123的新型单链抗体片段的可溶性表达与特性分析
Appl Biochem Biotechnol. 2016 Apr;178(7):1390-406. doi: 10.1007/s12010-015-1954-y. Epub 2016 Jan 9.
6
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.单链可变区抗体片段作为细胞毒性纳米颗粒靶向配体的全面优化
MAbs. 2015;7(1):42-52. doi: 10.4161/19420862.2014.985933.
7
[Selection and characterization of human scFv antibodies against hepatocellular carcinoma].[抗肝细胞癌人源单链抗体片段的筛选与鉴定]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Mar;24(3):256-9.
8
Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.用人源单链可变片段抗体靶向血管内皮生长因子抑制血管生成。
Microvasc Res. 2015 Jan;97:13-8. doi: 10.1016/j.mvr.2014.09.002. Epub 2014 Sep 22.
9
RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.RP215 单链片段可变区和单域重组抗体诱导乳腺癌细胞在 G0/G1 期停滞。
Mol Immunol. 2014 May;59(1):100-9. doi: 10.1016/j.molimm.2014.01.007. Epub 2014 Feb 14.
10
[Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].[针对MCF-7细胞构建噬菌体展示抗体库及筛选抗乳腺癌细胞的单链抗体]
Sheng Wu Gong Cheng Xue Bao. 2004 Sep;20(5):667-72.

引用本文的文献

1
Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer.靶向CD47和血管生成在膀胱癌中显示出有效的抗肿瘤作用。
Biomedicines. 2024 Sep 23;12(9):2152. doi: 10.3390/biomedicines12092152.
2
The Potential of Single-Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics.单链可变片段抗体的潜力:在未来治疗性和诊断性生物制剂中的作用。
J Immunol Res. 2024 Aug 9;2024:1804038. doi: 10.1155/2024/1804038. eCollection 2024.
3
Development of an ostrich-derived single-chain variable fragment (scFv) against PTPRN extracellular domain.
抗 PTPRN 细胞外结构域鸵鸟源单链可变片段(scFv)的研制。
Sci Rep. 2024 Feb 14;14(1):3689. doi: 10.1038/s41598-024-53386-5.
4
Applications of Magnetite Nanoparticles in Cancer Immunotherapies: Present Hallmarks and Future Perspectives.磁性纳米粒子在癌症免疫治疗中的应用:现状与未来展望。
Front Immunol. 2021 Oct 4;12:701485. doi: 10.3389/fimmu.2021.701485. eCollection 2021.
5
Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art.纳米技术作为可注射肠胃外制剂开发的平台:技术诀窍与最新进展综述
Pharmaceutics. 2020 Jun 3;12(6):510. doi: 10.3390/pharmaceutics12060510.
6
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.抗肿瘤治疗中针对 CD47/SIRPα 轴的研究进展。
Front Immunol. 2020 Jan 28;11:18. doi: 10.3389/fimmu.2020.00018. eCollection 2020.
7
Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy.检查点CD47在肿瘤转移和免疫治疗中的作用
Onco Targets Ther. 2019 Nov 4;12:9105-9114. doi: 10.2147/OTT.S220196. eCollection 2019.
8
Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.纳米卡介苗:一种治疗人类膀胱癌的有前景的递送系统。
Front Pharmacol. 2018 Jan 12;8:977. doi: 10.3389/fphar.2017.00977. eCollection 2017.
9
Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs.用于抗癌药物控释和靶向递送的石墨烯及氧化石墨烯的多功能化
Am J Transl Res. 2017 Dec 15;9(12):5197-5219. eCollection 2017.